Updates are available Correction dated 2021-08-23

Article History

Accepted: 14 June 2021

First Online: 12 July 2021

Change Date: 23 August 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40271-021-00545-9

Declarations

:

: This review was partially funded by AstraZeneca. AstraZeneca had no role in formulating the research question, data collection, analysis, or the decision to publish the results.

: Hannah Collacott, Dian Zhang, Sebastian Heidenreich, and Tommi Tervonen are employees of Evidera, which provides consulting and other research services to pharmaceutical, medical device, and related organisations. In their salaried positions, they work with a variety of companies and organisations and are precluded from receiving payment or honoraria directly from these organisations for services rendered.

: All study data is available from the corresponding author (Tommi Tervonen) on request.

: Tommi Tervonen takes responsibility for the content of the manuscript, including the data and analysis.

: Hannah Collacott, Sebastian Heidenreich, and Tommi Tervonen participated in study conception, design, and planning. Hannah Collacott and Dian Zhang participated in screening and analysis. All authors contributed to interpretation of the data. Hannah Collacott wrote the initial manuscript draft, and all authors were involved in reviewing.

: The authors would like to thank Ruth Pereira and Ileen Gilbert (AstraZeneca) for critical review of the manuscript draft, and Fritz Hamme (Evidera) for his editorial review of the manuscript.